MALIGNANT SPINAL CORD COMPRESSION, EARLY CLINICAL OUTCOME.
- Clinical Oncology & Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Egypt.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Introduction: Metastatic spinal cord compression (MSCC) is usually an oncological emergency and a well-recognized complication of cancer. Lung, prostate, multiple myeloma, non-Hodgkin lymphoma, and breast are the most common underlying tumors. These five types of malignancy, in addition to sarcomas and renal cancers account for about 70% of cases of metastatic epidural spinal cord compression. If untreated, metastatic epidural compression progresses, causing paralysis, sensory loss, and sphincter incontinence. Material and Methods: Prospective descriptive cross sectional study to assess prognostic factors and clinical outcome of malignant spinal compression among patients attending Suez Canal university hospital in period from 2016 to 2017. Results: A total of 48 patients were included in this study. Males accounting 45.8% and 54.2% were females. Breast cancer was the most incident (27%) to cause spinal cord compression. Dorsal vertebra was the most common site affected (45, 8%). Most of the studied patients (79.2%) presented with MSCC within less than 12 months from tumor diagnosis. 70.8% of studied population were managed by radiotherapy, 12.5% managed by surgery and 16.7% managed by both. The mean overall survival among the studied patients was 6.5 months. Conclusions: In Egypt, no documented data of incidence of MSCC. Most of MSCC cases (79%) were presented within less than 12 months from time of primary tumor diagnosis and that was significantly related to better post management functional outcome. After management of MSCC cases 50% showed improvement of motor function, no interval changes in (41.7%) and (8.3%) showed deterioration of motor function. After 6 months of follow up of MSCC 37.5% of cases have residual and 12.5% have recurrence or progression of disease.
- Abrahm, J. L. (2004). "Assessment and treatment of patients with malignant spinal cord compression." J Support Oncol 2(5): 377-388.
- Bach, F, Larsen BH, Rohde K, et al. (1990). "Metastatic spinal cord compression. Occurrence, symptoms, clinical presentation and prognosis " Actaneurochirurgica 107(1-2): 37-43.
- Bucholtz JD. ( 1999). Metastatic epidural spinal cord compression. SeminOncolNurs :15 3:150?159. [PubMed] [Google Scholar]
- David Schiff and Kathryn Nevel. (2011).metastatic spinal cord compression, epidemiology, section 7 of 14. 57.
- Douglas, S., Stefan Huttenlocher, AmiraBajrovic et al. (2012). "Prognostic factors for different outcomes in patients with metastatic spinal cord compression from cancer of unknown primary." BMC cancer 12:(1).
- Greyfriars Road, Cardiff. (2008). Metastatic spinal cord compression, the National Collaborating Centre for Cancer, CF10 3AF.
- Husband DJ, Grant KA and Romaniuk CS. (2001). MRI in the diagnosis and treatment of suspected malignant spinal cord compression. Br J Radiol; 74:15?23. [PubMed] [Google Scholar]
- Helweg-Larsen S, Sorensen PS, Kreiner S., et al. (2000). "Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients." International Journal of Radiation Oncology* Biology* Physics 46(5): 1163-1169.
- Ibrahim, A. S., Hussein M. Khaled, Nabiel NH Mikhail, et al. (2014). "Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program." Journal of Cancer Epidemiology: 18.
- Loblaw DA, Laperriere NJ and Mackillop WJ. (2003). "A population-based study of malignant spinal cord compression in Ontario." Clinical Oncology 15(4): 211-217.
- NaliniVadivelu, Richard D. Urman and Roberta L. Hines (2011) .Essentials of pain management: complete patient evaluation: motor strength evaluation: 65.
- Oken M, Creech R, Tormey D, et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J ClinOncol.; 5:649-655.
- Quraishi, N. A. and C. Esler (2011). "Metastatic spinal cord compression." BMJ 342(7): d2402.
- White, B., et al. (2008). "Diagnosis and management of patients at risk of or with metastatic spinal cord compression: summary of NICE guidance." BMJ (CR)-print 337(7): a2538.
- Rasool M T., Kaneez Fatima, NajmiArshadManzoor, et al. (2016). "Profile of malignant spinal cord compression: One year study at regional cancer center." Indian journal of palliative care 22(2): 125.
[Maha L.zamzam and Marwa A.suliman. (2019); MALIGNANT SPINAL CORD COMPRESSION, EARLY CLINICAL OUTCOME. Int. J. of Adv. Res. 7 (May). 786-795] (ISSN 2320-5407). www.journalijar.com
Clinical Oncology & Nuclear Medicine Department, Faculty of Medicine, Suez Canal University, Egypt